Epiandrosterone

Epi-Andro · 3β-Androsterone · Isoandrosterone · trans-Androsterone · Stane

Last updated

SteroidProhormone (DHT Precursor)Grey-Marketgrey-market
Best forStrength 5/10
Cycle4–8wk
RiskHigh
43 min read
Half-LifeUnknown
Bioavailability3%
RouteOral
Dose Unitmg
Cycle4–8 weeks
Peak2h
Active Duration12h
MW290.44 g/mol
StorageRoom temp

At a glance

Effectiveness Profile
Loading effectiveness chart
Strength
5/10
Muscle Growth
4/10
Fat Loss
3/10
Recovery
3/10
Endurance
2/10
Cognition
2/10
Anabolic Rating

40

Testosterone = 100

Androgenic Rating

55

Testosterone = 100

Overview

Epi-andro earned its spot in the grey-market prohormone playbook for one specific reason: it's the cleanest way to run a non-aromatizing DHT precursor without touching a 17α-alkylated oral. Oxidized by 3β-HSD and reduced at the 17-keto, epiandrosterone converts in vivo to dihydrotestosterone — delivering the dry, hard, vascular phenotype that physique-focused users chase on a cut or contest peak, with none of the estrogenic bloat and essentially none of the hepatotoxicity you get from epistane, M1T, or superdrol.

"Epiandrosterone, which is the 5α-reduced DHEA with a 3β-hydroxy-5α-androstan-17-one structure, exhibits androgenic activity after its enzymatic oxidation by 3β-hydroxysteroid dehydrogenase (3β-HSD) and subsequent reduction to DHT." — El Kihel, Steroids (2012)

It's not a mass builder and it shouldn't be treated as one. Scale weight barely moves; the mirror does. The community runs it for a Masteron-lite finish on top of an AAS cycle, as a standalone dry recomp tool for natural users who want something with real teeth, or stacked with 1-Andro or 4-Andro for fully non-aromatizing "wet + dry" runs. Strength goes up, pumps sharpen, and the dry-skin look lands by about week three — provided you're running a properly formulated cyclodextrin or liposomal product, because unformulated raw powder barely clears first-pass metabolism.

The rest of this page covers what you actually need to run it well: dose ladders from first-cycle through advanced, cycle length and stacking (solo, with 1-Andro, with 4-Andro, and as a back-end hardener), PCT protocols, the real side-effect profile (hair, lipids, prostate, BP) and how to mitigate each, plus monitoring bloodwork and the common pitfalls that sink otherwise well-designed cycles.

How Epiandrosterone works

Epi-andro is not itself a meaningful androgen receptor agonist — it's a pro-drug. The whole point of the molecule is that it sits one enzymatic step upstream of 5α-dihydrotestosterone (DHT), and your own liver does the conversion. Everything the compound "does" in the mirror is downstream of that hand-off.

Two-Step Enzymatic Conversion to DHT#

Epiandrosterone is a 5α-reduced, 3β-hydroxy C19 steroid — structurally, DHT with the wrong hydroxyl on the A-ring and the wrong oxidation state at C17. Hepatic 3β-hydroxysteroid dehydrogenase (3β-HSD / 3β-HSOR) oxidizes the 3β-OH to a ketone, producing 5α-androstane-3,17-dione. 17β-HSD then reduces the C17 ketone to a β-hydroxyl, yielding DHT (stanolone).

"Epiandrosterone, which is the 5α-reduced DHEA with a 3β-hydroxy-5α-androstan-17-one structure, exhibits androgenic activity after its enzymatic oxidation by 3β-hydroxysteroid dehydrogenase (3β-HSD) and subsequent reduction to DHT." — El Kihel, L. Steroids, 2012

"It was shown that DHEA and epiandrosterone serve as substrates for human hepatic 3beta-hydroxysteroid oxidoreductase (HSOR), leading to the formation of 5α-androstanedione and ultimately to DHT." — Chalbot S, Morfin R. Drug Metab Dispos, 2005

Practical consequence: because DHT is generated downstream of 5α-reductase, finasteride and dutasteride will not protect your hairline on epi-andro. If you're MPB-prone, topical AR antagonists (RU58841, pyrilutamide) are the only mechanistically sensible scalp defense on cycle.

DHT at the Androgen Receptor — Dry, Hard, No Estrogen#

DHT binds the androgen receptor with roughly three times the affinity of testosterone and dissociates more slowly, producing stronger per-molecule AR signalling in skeletal muscle, CNS, and sebaceous tissue. That drives the usual AR-mediated physique outcomes: increased myofibrillar protein synthesis, amino-acid uptake, satellite cell activation, and strength-per-bodyweight.

The defining feature for physique users is what DHT cannot do: the A-ring is already saturated, so the molecule is not a substrate for aromatase. No estrogen conversion, no water retention, no gyno risk, no E2-driven fat patterning. This is why the subjective feel of an epi-andro run is "harder, drier, tighter" rather than "fuller, heavier, wetter" — you're running a purely androgenic signal with no estrogenic counterweight. It's also why the scale barely moves while the mirror improves: dry lean tissue and reduced subcutaneous water, not glycogen-and-fluid bulk.

Why Oral Bioavailability Is the Whole Game#

Epiandrosterone taken as raw powder is largely wasted. Orally dosed 17-ketosteroids in this family undergo aggressive first-pass sulfation and glucuronidation in the gut wall and liver before they can even reach the 3β-HSD conversion step.

"Oral administration of dehydroepiandrosterone and related androstane derivatives results in extensive first-pass hepatic metabolism with a bioavailability of approximately 3% in primate models." — Leblanc M et al. J Clin Endocrinol Metab, 2003

Practical consequence: the commercial products that work (cyclodextrin-complexed, liposomal, "Cyclosome") aren't marketing gimmicks — the delivery format is doing most of the work. A 500 mg/day dose of unformulated powder delivers a fraction of a 330 mg/day dose of a properly complexed product. Always dose with dietary fat to exploit lymphatic uptake and bypass a portion of first-pass.

Non-Methylated Structure — Minimal Hepatotoxicity#

Unlike true 17α-alkylated orals (superdrol, M1T, epistane, dianabol), epiandrosterone has no C17α methyl group. It doesn't need one — it's not trying to survive first-pass as the active molecule; it's trying to reach the liver and get converted there. That structural choice is the reason AST/ALT typically stay in range on standard doses, and it's the single biggest reason epi-andro gets tolerated for 6–8 week cycles where a real methyl like M1T would be a 2–4 week proposition.

TUDCA at 250–500 mg/day is reasonable precaution, not a mechanistic necessity. The real organ system taking the hit on this compound is your lipid panel, not your hepatocytes.

Off-Target Pharmacology Worth Knowing#

Epiandrosterone has a few non-AR actions that matter at higher doses:

  • L-type calcium channel blockade in cardiac myocytes — documented in vitro and relevant at supraphysiological exposures.

"Epiandrosterone blocks L-type Ca²⁺ channels in ventricular myocytes at micromolar concentrations, resulting in a negative inotropic effect that could become relevant at supraphysiological exposures." — Gupte SA et al. J Mol Cell Cardiol, 2002

  • Weak GABA-A negative allosteric modulation — contributes to the mild mood-lift / stimulatory feel some users report, similar to other 3β-hydroxy neurosteroids.
  • G6PDH / pentose phosphate pathway inhibition — cited historically as the rationale for epiandrosterone's "hypolipidemic" label in early literature, though in practice oral androgen exposure dominates and lipids trend worse on cycle, not better.

Net Practical Picture#

You're taking an oral pro-drug that your liver converts into DHT. You get dry strength, AR-driven hardness, no aromatization, no serious hepatotoxicity, and suppressed HPTA output that needs a proper SERM PCT on the back end. The side-effect profile — HDL drop, accelerated scalp loss in genetically susceptible users, mild BP creep, prostate sensitivity — is the DHT profile, full stop. Manage those on cycle (bergamot/fish oil, topical AR antagonist, daily low-dose tadalafil) and epi-andro is one of the cleaner grey-market tools for a dry recomp or hardening finisher.

Protocol

LevelDoseFrequencyNotes
Low250–300 mgTwice dailyDocumented entry-level range
Mid400–500 mgTwice dailyMost commonly studied range
High600–750 mgTwice dailySplit AM/PM with meals. Advanced users sometimes run 3× daily. Take with dietary fat to improve absorption of the lipophilic steroid.

Cycle length & outcomes

Documented cycle

4–8 weeks

Cycle Structure#

Epi-andro is a non-methylated DHT prohormone — no loading phase, no ramp-up, no ester kinetics to manage. It is orally dosed and converted, with the "dry and hard" feel appearing around day 10–14. Because it can't aromatize, there's no wet-to-dry transition mid-cycle and no estrogen rebound at the end. What you do have to plan for is HPTA suppression (mild-to-moderate), lipid drag, and a mandatory SERM PCT.

Run length lives in the 4–8 week window. Under four weeks is barely worth the suppression; past eight, diminishing returns on muscle/strength collide with accelerating HDL drop and hairline anxiety. Six weeks is the sweet spot for most users.

Dose Ladder by Goal#

GoalCycle LengthDaily DoseSplit
First cycle / recomp feel-out4 weeks250–300 mgAM + PM with meals
Dry cut / aesthetic hardening4–6 weeks400–500 mgAM + PM with meals
Lean bulk (stacked with 1-andro)5–6 weeks300–400 mgAM + PM with meals
Strength peak / advanced standalone6–8 weeks600–750 mg3× daily with meals
AAS cycle hardening finisherFinal 4 weeks of cycle500 mgAM + PM with meals

Dose with dietary fat — epiandrosterone is lipophilic and absorption meaningfully improves alongside a meal containing 15+ g fat. This is the single easiest variable to optimize.

Onset Timing#

  • Days 1–7: Little to nothing. Some users report a subtle mood/aggression lift by day 4–5 from GABA-A modulation.
  • Days 7–14: Strength climbs noticeably. Pumps get denser. Skin starts to tighten visually.
  • Weeks 3–5: Peak effect window — visible hardening, vascularity, a measurable strength bump (community logs run 5–15 lb on main lifts). This is where the mirror changes.
  • Weeks 6–8: Diminishing returns curve flattens; suppression deepens. Libido and morning wood often dip here.

"Epiandrosterone … exhibits androgenic activity after its enzymatic oxidation by 3β-HSD and subsequent reduction to DHT." — El Kihel, Steroids (2012)

The two-step conversion is why epi-andro is slower-feeling than a true DHT injectable like Masteron — you're waiting on enzymatic throughput, not direct receptor occupancy.

Formulation Matters More Than Dose#

"Oral administration of dehydroepiandrosterone and related androstane derivatives results in extensive first-pass hepatic metabolism with a bioavailability of approximately 3% in primate models." — Leblanc et al., JCEM (2003)

Raw epiandrosterone powder is effectively inert orally. Any real cycle requires a cyclodextrin-complexed, liposomal, or "Cyclosome" formulation — Androvar, Super-DMZ Rx, and similar retail products are built this way for a reason. If you're comparing a 330 mg formulated capsule to 500 mg of bulk powder, the capsule wins easily. This is the single biggest mistake on first cycles.

Bloodwork Cadence#

TimepointPanel
Pre-cycle baselineTotal/free T, LH, FSH, E2, full lipids, AST/ALT, CBC, BP
Week 3–4 (mid-cycle)Lipids, AST/ALT, BP (home cuff)
End of cycle → PCT startTotal T, LH, FSH
Week 10–12 (post-PCT)Total T, LH, FSH, lipids — confirm recovery

Non-methylated status keeps liver values boringly in-range for most users, but lipids will move — expect HDL to drop 10–25% and LDL to nudge up. Citrus bergamot 500–1000 mg/day and 2–4 g fish oil daily take the edge off; back-to-back cycles without a lipid recovery window are the fastest way to earn a cardiology referral in your 40s.

PCT Timing#

Start SERM PCT the day after your last dose — no clearance gap needed given epi-andro's short functional duration.

  • Nolvadex: 20/20/10/10 mg over 4 weeks (preferred for most users — kinder on lipids than clomid)
  • Clomid: 50/50/25/25 mg over 4 weeks (alternative)

Natty support (tongkat, ashwagandha, DAA) can ride alongside but is not a replacement. Running a 500 mg × 6 week cycle without a SERM and hoping you "bounce back" is how people end up on TRT at 32.

Time Off#

Minimum time-off = time-on + PCT length. A 6-week cycle + 4-week PCT means at least 10 weeks clean before the next run. Lipids and HPTA both want that window. Two to three cycles per year is the sustainable ceiling — more than that and you're quietly turning a prohormone habit into a low-dose oral AAS habit with worse pharmacokinetics.

Loading outcome projection

Risks & mistakes

Common (most users)#

  • Oily skin and acne — DHT is doing what DHT does. Daily salicylic acid cleanser, niacinamide serum, and keeping dietary dairy/sugar in check handle most of it. If it's escalating to cystic, the dose is too high or the individual's genetics may not tolerate DHT loads.
  • Accelerated scalp hair shedding (if MPB-prone) — this is the single most common reason users quit epi-andro. Oral 5AR inhibitors will not save you here — the DHT is delivered downstream of 5α-reductase. Topical RU58841 or pyrilutamide (AR antagonists at the follicle) are the only mechanistically valid scalp defenses during a cycle. If a receding hairline is already present, choose an alternative compound.
  • Libido swings — strong libido and morning wood for the first 2–3 weeks, then a dropoff as HPTA suppression kicks in. Daily tadalafil 2.5–5 mg smooths this out and pulls double duty for BP and prostate.
  • Aggression / assertiveness uptick — typical DHT tone. Usually wanted. Keep it out of the cage in week 3–4 when sleep may also be lighter.
  • Mild BP rise — cuff at home 2–3×/week. Citrus bergamot, cardio 3×/week, and sodium discipline keep it in check. If resting is pushing past 135/85, back down.
  • "Flat" look for the first 7–10 days — epi-andro doesn't aromatize, so you lose the estrogenic water softness early in the cycle before the DHT hardening kicks in. Don't panic-dose higher.

Uncommon (dose-dependent or individual)#

  • Lipid drag — HDL down, LDL up. Predictable for any oral non-aromatizing androgen, even without 17α-alkylation. Get a baseline panel pre-cycle and recheck at week 3–4. If HDL drops below 35 mg/dL or LDL goes past 160, cut the dose or end the cycle early. Citrus bergamot 500–1000 mg/day and fish oil 2–4 g/day are the standard blunting stack.
  • Prostate fullness / frequent urination — DHT-mediated prostatic growth. Daily tadalafil 2.5–5 mg resolves this for most users. If it persists or there's hesitancy/incomplete voiding, pull the cycle.
  • Mood / sleep disruption at higher doses (600–750 mg/day) — light sleep, waking hot, increased irritability. Drop to 400–500 mg/day.
  • Suppressed morning wood by week 4–5 — expected signal that LH/FSH are down. Not a problem during the cycle; it's the reason PCT is non-negotiable.
  • Gut / GI upset — usually the formulation, not the molecule. Take with meals containing fat.

Rare but serious#

  • Hypertensive crisis — anyone running epi-andro on top of untreated hypertension is courting this. Warning signs: headache that won't quit, visual disturbance, resting BP >160/100. Stop immediately.
  • Cardiac symptoms at supraphysiological exposures — high-dose in vitro work shows L-type Ca²⁺ channel blockade and negative inotropy in ventricular myocytes.

"Epiandrosterone blocks L-type Ca2+ channels in ventricular myocytes at micromolar concentrations, resulting in a negative inotropic effect that could become relevant at supraphysiological exposures." — Gupte et al., J Mol Cell Cardiol (2002)

Clinically relevant only at abusive doses, but it's the mechanistic reason mega-dosing this compound is a bad idea.

  • Persistent HPTA suppression past a standard 4-week PCT — uncommon at 4–6 week cycle lengths, more likely with 8-week runs or back-to-back cycles without full recovery. Bloodwork (LH, FSH, total T) 6–8 weeks post-PCT is how you catch it. If T is still suppressed, you need an endocrinology workup, not another PCT round.
  • Severe acne / scarring breakouts — in genetically susceptible users, epi-andro can trigger the kind of cystic acne that needs isotretinoin to resolve. If the first 2 weeks show aggressive cystic activity, end the cycle.

Hard contraindications#

  • Active or prior prostate cancer or hormone-sensitive cancer — DHT drives growth. Non-negotiable.
  • Untreated hypertension or dyslipidemia — control these before you start an oral androgen, not while you're running one.
  • Planned conception within the next 6 months — HPTA suppression hits LH/FSH and semen parameters. Finish a cycle, run full PCT, recheck bloodwork, then try.
  • Pregnancy or possibility of pregnancy — androgens are teratogenic to a female fetus. Do not handle or dose.
  • Female use — epi-andro converts to DHT in vivo. Virilization (voice deepening, clitoral enlargement, androgenic hair pattern changes) is real and past a threshold is not reversible. Women looking for recomp have better tools.
  • Tested athletes — WADA-banned and detectable on standard urinary androgen-metabolite panels via epiandrosterone-glucuronide. There is no "clean" window.
  • Advanced male pattern baldness where hair retention matters to you — this is a DHT delivery vehicle. That's the entire mechanism. Pick a different compound.

Gender & PCT considerations#

Women: not recommended at any dose. The DHT conversion pathway is the whole point of the compound, and the virilization risk it carries (voice, clitoral tissue, androgenic hair pattern) has a partial-irreversibility threshold that sneaks up on users. Anavar or low-dose primobolan are the conventional female-tolerable picks — epi-andro isn't.

Men — PCT: run it, even though the marketing calls this a "mild" prohormone. Bloodwork from 6-week users consistently shows meaningful LH/FSH drops.

Cycle lengthPCT protocol
4 weeks, ≤400 mg/dayNolvadex 20/20/10/10 (4 weeks)
6 weeks, 400–500 mg/dayNolvadex 20/20/20/10 or Clomid 50/50/25/25 (4 weeks)
8 weeks or 600+ mg/dayClomid 50/50/25/25 + Nolvadex 20/20/20/20 (4 weeks)

Support: natural test-support stack (DAA, tongkat, ashwagandha) layered on top is fine but not a substitute for a SERM. Recheck total T, LH, and FSH 4 weeks after PCT ends to confirm recovery before planning the next cycle. Give lipids 6–8 weeks clean between runs — don't blast-and-cruise a prohormone.

Stack & combine

Pairwise synergies

Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.

PartnerTypeLeanFat lossRecovery
synergistic×1.03×1.00×1.15

FAQ — Epiandrosterone

PCT & ancillaries

These are separate products from our affiliate partners, not Epiandrosterone offers. Their inclusion does not mean they are required or recommended for use.

Real Peptides

Real Peptides

Our pick
Ships from USPeptide specialistVials, capsules & sprays

20% off — auto-applied at checkout

NextChems

NextChems

Ships from USCapsules & solutions available

10% off — auto-applied at checkout

Swiss Chems

Swiss Chems

Ships from USWidest catalogCapsules, powders & injectables

10% off — auto-applied at checkout

Research & citations

5 studies cited on this page.

Conclusion

Epi-andro is the no-nonsense choice for dry strength, hardening, and vascularity when you want a DHT-driven look without managing estrogen.

Key takeaways:

  • Standard cycle: 400–500 mg/day oral (cyclodextrin/liposomal) split AM/PM, 4–6 weeks
  • Bioavailability is poor unless you use a formulated (not raw powder) product
  • Stacks well with 1-Andro or 4-Andro for lean or balanced cycles
  • Does not aromatize — expect dry muscle, strength, and visible muscle separation, not big scale weight jumps
  • Full SERM-based PCT is required — think nolvadex 20/20/10/10 or clomid 50/50/25/25
  • Real DHT-driven side effects: MPB acceleration and mild HDL suppression are the big flags; topical AR blockers help hair, citrus bergamot for lipids

If you want a reliable, low-bloat hardening prohormone with clear lines of strength and muscle detail, epi-andro is one of the most user-proven options in the category. Use it intelligently and you get a dry, dense look without the legal heat or liver hit of harsher orals.

Similar compounds

Comparisons

Disclosures

Affiliate links — we may earn a commission at no cost to you.